Company Description
Zerospo is one of the leading medical relaxation service providers in Japan.
We utilize judo therapists and acupuncture and moxibustion therapists to treat our clients, who primarily consist of professional and non-professional athletes.
Judo therapists are therapists that do not rely on surgery or administration of medicine, but instead give patients certain treatments of reduction and immobilization against physical injuries like fracture, dislocation, bruise, sprain, and contusion.
Judo therapists are focused on maximizing the healing capacity of the human body and are distinctly different from those who merely provide a relaxing massage and adjustments to mitigate chronic symptoms (e.g., to correct a pelvic/spinal tilt).
Moxibustion therapists are therapists that stimulate pressure points of the human body with acupuncture (stimulation therapy) and moxa (thermotherapy) in order to help patients enhance their natural curative power against disease.
In order to increase our footprint, we expanded our operations outside of the Tokyo metropolitan area into the central, northern, and western regions of Japan.
The number of our salons in the non-Tokyo metropolitan area has grown to 12, accounting for almost one-third of our total salons.
| Country | Japan |
| Founded | 2001 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| Employees | 310 |
| CEO | Yoshio Ukaji |
Contact Details
Address: Higashiooi Urbanheim, 3F 5-19-9, Higashiooi, Shinagawa, Tokyo Japan | |
| Phone | +81 90-2528-8139 |
| Website | zerospo.com |
Stock Details
| Ticker Symbol | ZRSP |
| Exchange | NASDAQ |
| Fiscal Year | November - October |
| Reporting Currency | USD |
| CIK Code | 0001962833 |
| SIC Code | 8000 |
Key Executives
| Name | Position |
|---|---|
| Yoshio Ukaji | Chief Executive Officer, Chairman and Director |
| Tadao Ukaji | Chief Administrative Officer and Director |
| Daisaku Kadomae | Chief Financial Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Jan 16, 2024 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Dec 21, 2023 | 8-A12B | Registration of securities |
| Dec 20, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Nov 8, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Oct 20, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 28, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Sep 8, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| Jun 13, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| May 25, 2023 | F-1/A | [Amend] Registration statement for certain foreign private issuers |
| May 1, 2023 | F-1 | Registration statement for certain foreign private issuers |